H.Z. Ke

1.6k total citations
25 papers, 1.2k citations indexed

About

H.Z. Ke is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Genetics. According to data from OpenAlex, H.Z. Ke has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Orthopedics and Sports Medicine and 7 papers in Genetics. Recurrent topics in H.Z. Ke's work include Bone health and osteoporosis research (10 papers), Bone Metabolism and Diseases (7 papers) and Estrogen and related hormone effects (6 papers). H.Z. Ke is often cited by papers focused on Bone health and osteoporosis research (10 papers), Bone Metabolism and Diseases (7 papers) and Estrogen and related hormone effects (6 papers). H.Z. Ke collaborates with scholars based in United States, China and Malaysia. H.Z. Ke's co-authors include David D. Thompson, Hollis A. Simmons, C.M. Pirie, David T. Crawford, X.G. Liang, W.S.S. Jee, Thomas A. Brown, Yujie Ma, Lynda F. Bonewald and Thomas A. Owen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Endocrinology.

In The Last Decade

H.Z. Ke

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.Z. Ke United States 17 668 443 373 263 133 25 1.2k
H. Herschel Conaway United States 17 826 1.2× 237 0.5× 446 1.2× 109 0.4× 74 0.6× 33 1.3k
Y.F. Ma United States 15 336 0.5× 324 0.7× 317 0.8× 162 0.6× 114 0.9× 30 756
Mariana Kiomy Osako Japan 20 421 0.6× 220 0.5× 253 0.7× 83 0.3× 37 0.3× 40 1.2k
Ursula Föger‐Samwald Austria 11 416 0.6× 268 0.6× 159 0.4× 68 0.3× 23 0.2× 26 760
B.J. Riis Denmark 17 196 0.3× 138 0.3× 112 0.3× 75 0.3× 112 0.8× 40 1.9k
Yaohua Ke China 16 248 0.4× 142 0.3× 151 0.4× 203 0.8× 18 0.1× 38 824
Mette G Sørensen Denmark 14 591 0.9× 199 0.4× 324 0.9× 62 0.2× 46 0.3× 18 802
N Ida Japan 15 700 1.0× 77 0.2× 561 1.5× 58 0.2× 66 0.5× 27 1.5k
Siru Zhou China 18 616 0.9× 79 0.2× 110 0.3× 94 0.4× 98 0.7× 42 1.1k
Lidia Ibáñez Spain 12 537 0.8× 129 0.3× 184 0.5× 62 0.2× 53 0.4× 18 804

Countries citing papers authored by H.Z. Ke

Since Specialization
Citations

This map shows the geographic impact of H.Z. Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.Z. Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.Z. Ke more than expected).

Fields of papers citing papers by H.Z. Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.Z. Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.Z. Ke. The network helps show where H.Z. Ke may publish in the future.

Co-authorship network of co-authors of H.Z. Ke

This figure shows the co-authorship network connecting the top 25 collaborators of H.Z. Ke. A scholar is included among the top collaborators of H.Z. Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.Z. Ke. H.Z. Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ke, H.Z., et al.. (2025). Machine learning models of depression in middle-aged and older adults with cardiovascular metabolic diseases. Journal of Affective Disorders. 387. 119494–119494. 2 indexed citations
3.
Spatz, Jordan, Alison Cloutier, Leeann Louis, et al.. (2017). Sclerostin antibody inhibits skeletal deterioration in mice exposed to partial weight-bearing. Life Sciences in Space Research. 12. 32–38. 12 indexed citations
4.
Ke, H.Z., et al.. (2016). Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Aguirre, J. Ignacio, M. P. Akhter, Alyssa Williams, et al.. (2016). Age-related periodontitis and alveolar bone loss in rice rats. Archives of Oral Biology. 73. 193–205. 17 indexed citations
6.
Ke, H.Z., et al.. (2008). Periodontal Breakdown in the Dmp1 Null Mouse Model of Hypophosphatemic Rickets. Journal of Dental Research. 87(7). 624–629. 49 indexed citations
7.
8.
Pan, Lydia C., Hollis A. Simmons, David R. Healy, et al.. (2006). Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice. Bone. 39(4). 796–806. 42 indexed citations
9.
Ke, H.Z., et al.. (2006). Selective androgen receptor modulators--prospects for emerging therapy in osteoporosis?. PubMed. 5(4). 355–355. 1 indexed citations
10.
Ke, H.Z.. (2004). Implications of PDE4 structure on inhibitor selectivity across PDE families. International Journal of Impotence Research. 16(S1). S24–S27. 24 indexed citations
11.
12.
Ke, H.Z., V. Shen, Hongyi Qi, et al.. (1998). Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Bone. 23(3). 249–255. 47 indexed citations
13.
14.
Thompson, David D., Hollis A. Simmons, C.M. Pirie, & H.Z. Ke. (1995). FDA guidelines and animal models for osteoporosis. Bone. 17(4). S125–S133. 385 indexed citations
15.
Ke, H.Z., Hongyi Qi, C.M. Pirie, et al.. (1995). Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone. 17(5). 491–496. 35 indexed citations
16.
Ke, H.Z.. (1995). Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology. 136(6). 2435–2441. 26 indexed citations
17.
Ke, H.Z., Hollis A. Simmons, C.M. Pirie, David T. Crawford, & David D. Thompson. (1995). Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.. Endocrinology. 136(6). 2435–2441. 97 indexed citations
18.
Mann, Gary N., Thomas Jacobs, Farrel J. Buchinsky, et al.. (1994). Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.. Endocrinology. 135(3). 1077–1083. 56 indexed citations
19.
20.
Ke, H.Z., et al.. (1993). Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.. Proceedings of the National Academy of Sciences. 90(8). 3324–3328. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Herschel Conaway Breakdown of academic impact, for papers by Y.F. Ma Breakdown of academic impact, for papers by Mariana Kiomy Osako Breakdown of academic impact, for papers by Ursula Föger‐Samwald Breakdown of academic impact, for papers by B.J. Riis Breakdown of academic impact, for papers by Yaohua Ke Breakdown of academic impact, for papers by Mette G Sørensen Breakdown of academic impact, for papers by N Ida Breakdown of academic impact, for papers by Siru Zhou Breakdown of academic impact, for papers by Lidia Ibáñez
Rankless by CCL
2026